AI Model for Cervical Cancer Detection From Colposcopy Images
NCT06644248
Summary
Cervical cancer is a significant health issue, particularly in low-income countries, where late diagnosis and limited access to screenings contribute to high mortality rates. This study aims to develop and evaluate an artificial intelligence (AI) model to analyze colposcopic images for detecting cervical cancer more accurately and efficiently. Colposcopy, a procedure used to examine the cervix for signs of cancer, relies heavily on doctors' expertise, leading to inconsistent results. The current gold standard, colposcopy-directed biopsy, is invasive and can cause complications. The hypothesis is that an AI model can outperform traditional methods in identifying cervical abnormalities, providing a reliable and scalable solution for early detection, especially in underserved areas. By automating the analysis process, the AI model aims to reduce reliance on trained personnel, making cervical cancer screening more accessible and improving early diagnosis and treatment outcomes. The study will create a diverse dataset of colposcopy images from various sources and develop the AI model. The model's performance will be validated in clinical settings, assessing its accuracy in classifying cancer stages and identifying transformation zones. The impact on early detection, patient outcomes, and model usability will be evaluated, as well as its generalizability across different healthcare environments. The goal is to enhance the accuracy and efficiency of cervical cancer screening, ultimately reducing mortality rates and improving patient care.
Eligibility
Inclusion Criteria: * Female patients of age 18 years or older can be selectedas subjects. * Individuals willing to participate in cervical cancerscreening. * Availability for colposcopic examination. * Women with no history of hysterectomy (total removalof the uterus). * Women with no current or prior diagnosis of cervicalcancer. * Availability of relevant medical records forconfirmation and comparison purposes. Exclusion Criteria: * Pregnant women, given the potential impact onscreening results and the need for specialconsiderations during pregnancy. * Individuals with severe medical conditions orcircumstances that may make colposcopic examinationinappropriate or unsafe. * Patients with conditions that could interfere with theaccuracy of the screening results, such as severevaginal bleeding. * Follow-up screenings.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06644248